Home › Alcohol Use Disorder (AUD) › NCT07178990
Mobile Platform for Optimizing Wellness and Engagement in Recovery
Recruiting
Who can join
Ages 19 to 63 · All sexes
Full eligibility criteria
Inclusion Criteria: * Participants must be enrolled in the Michigan Medicaid program * Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone * Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening * Participants must have regular access to a working smartphone and internet connection. * Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests). Exclusion Criteria: * Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group * Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency * Individuals with substantial cognitive impairment that would interfere with study participation * Individuals unable to read or understand English * Individuals experiencing active suicidality or psychosis. * Individuals with a planned admission to residential treatment or incarceration during the study period.
About the study
This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.
What is being tested
- Digital Contingency Management Intervention Arm (behavioral)
- Digital Wellness Arm (behavioral)
Sponsor: University of Michigan · Participants: 50 · Started: Dec 8, 2025
Contact the study team
- Haley Stevens · Phone: 734-764-9910
Official record on ClinicalTrials.gov — NCT07178990
Locations in the U.S.
| Michigan | University of Michigan, Ann Arbor |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.